You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 266 No. 6, August 14, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human Factor IX for the Treatment of Hemophilia B

Lisa J. Cardo, MD
Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY

JAMA. 1991;266(6):794.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—A 66-year-old man, who tested positive for the human immunodeficiency virus, with a history of hemophilia B (partial thromboplastin time, 75 seconds; factor IX activity, less than 1%), adult-onset diabetes mellitus, hypertension, stable angina, congestive heart failure, oral candidiasis, and Pneumocystis carinii pneumonia presented to the emergency department with a fever and a change in mental status manifested by confusion. Neurological examination revealed no focal neurological deficits. Emergency computed tomographic scan with contrast showed diffuse cortical atrophy. Since intracranial hemorrhage is a leading cause of mortality among hemophilic patients,1-3 a lumbar puncture was indicated to rule out any evidence of bleeding or infection. The patient had received prothrombin complex concentrates for past episodes of joint bleeding and tooth extraction. On more than one occasion this had resulted in disseminated intravascular coagulation, a known complication of the administration of this product. In addition, with the last administration . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.